Idiopathic granulomatous mastitis: Looking for the most effective therapy with the least side effects according to the severity of the disease in 374 patients in Iran.
idiopathic granulomatous mastitis
therapeutic modalities
Journal
The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
05
09
2018
revised:
10
09
2018
accepted:
13
09
2018
pubmed:
16
5
2019
medline:
14
1
2020
entrez:
16
5
2019
Statut:
ppublish
Résumé
The goal of this study is to compare the response rate and the recurrence rate of available therapeutic modalities in the treatment of Idiopathic Granulomatous Mastitis (IGM). 374 patients with pathologically confirmed IGM, were included. They were subdivided into three levels of severity. Close observation had the best response rate with the lowest recurrence rate in mild to moderate cases. Severe cases were mostly treated by prednisolone or underwent surgery. The outcome of prednisolone use in severe cases was comparable to NSAIDs. Overall 9% were resistant to treatment and surgical intervention is still an option among them.
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Naproxen
57Y76R9ATQ
Prednisolone
9PHQ9Y1OLM
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
672-677Informations de copyright
© 2019 Wiley Periodicals, Inc.